Company Description
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing.
The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers.
It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 2007 |
| IPO Date | Feb 21, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 92 |
| CEO | Dr. Douglas Murphy-Chutorian M.D. |
Contact Details
Address: 2340-2348 Walsh Avenue, Suite 2344 Santa Clara, California 95051 United States | |
| Phone | 408-627-4557 |
| Website | semlerscientific.com |
Stock Details
| Ticker Symbol | SMLR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001554859 |
| CUSIP Number | 81684M104 |
| ISIN Number | US81684M1045 |
| Employer ID | 26-1367393 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Douglas Murphy-Chutorian M.D. | Chief Executive Officer, President and Director |
| Renae Cormier | Chief Financial Officer, Principal Accounting Officer, Head of Corporate Communications and Business Strategy and Secretary |
| Dr. Herbert J. Semler | Founder and Chairman Emeritus |
| Jennifer Oliva Herrington | Chief Operating Officer |
| Shane Reid | Chief Technology Officer |
| Cindy Guinasso | Senior Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 6, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Jun 6, 2024 | 8-K | Current Report |
| May 28, 2024 | 8-K | Current Report |
| May 8, 2024 | 10-Q | Quarterly Report |
| May 7, 2024 | 8-K | Current Report |
| Mar 7, 2024 | 10-K | Annual Report |
| Mar 5, 2024 | 8-K | Current Report |
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 26, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 22, 2024 | 8-K | Current Report |